Investing 분야의 글 330개. 최신 글부터 순서대로 정리했습니다.
McCormick (MKC) stock analysis — $65B Unilever Foods merger, Frank's RedHot, Cholula, Old Bay, French's mustard, B2B Flavor Solutions, 39-year dividend growth (Dividend Aristocrat). Is MKC a buy at $46.83 in 2026?
Clorox (CLX) stock analysis — full recovery from the Aug 2023 cyberattack, IGNITE strategy, Glad/Brita/Burt's Bees portfolio strength, 49-year dividend streak, CEO transition, and valuation at $96. Is CLX a buy in 2026?
General Mills (GIS) stock analysis — Blue Buffalo pet food growth thesis, GLP-1 cereal demand fears examined, FY2025 revenue $19.49B, EPS $4.10, dividend yield 7%+. P/E 8.3x. Is this a value trap or the deepest discount in consumer staples right now?
Keurig Dr Pepper (KDP) stock analysis — JDE Peet's acquisition closed April 2026, Starbucks K-Cup partnership expanded, Q1 2026 net sales +8.1%. Forward P/E 12.6x vs Coca-Cola 24x. Is KDP's discount to peers an opportunity or a value trap?
Medical Properties Trust (MPW) deep dive — Steward Health bankruptcy May 2024, distribution cuts, $5.13 stock price (May 2026), Q1 2026 FFO $0.22 beat, tenant diversification progress, asset sales. Recovery narrative vs structural risks analyzed.
Hess Corporation (HES) deep dive — Chevron acquisition completed July 18, 2025 at 1.025 CVX per HES share. Guyana Stabroek 30% stake, ICC arbitration with ExxonMobil/CNOOC, Bakken assets. What the deal means for CVX investors in 2026.
Energy Transfer (ET) analysis — 7.5% distribution yield, Dakota Access Pipeline, Lake Charles LNG, Rover Pipeline. The 2020 distribution cut history, GP/LP governance concerns, and the K-1 problem that most yield-chasing summaries omit.
Enterprise Products Partners (EPD) deep dive — 25+ years of distribution growth, Mont Belvieu NGL dominance, 1.7× DCF coverage. The honest case for why international investors should buy KMI or WMB instead.
Kenvue (NYSE: KVUE) stock analysis — Tylenol, Listerine, Neutrogena, Band-Aid, Aveeno. FY2025 revenue $15.1B, ~3.8% dividend yield, JNJ stake selldown nearing completion. Consumer healthcare giant at a crossroads between overhang resolution and growth reacceleration.
ResMed (NYSE: RMD) stock analysis — AirSense 11 platform, Philips recall windfall locked in, GLP-1 impact with real adherence data, Brightree/MatrixCare SaaS margin lift. TTM revenue $5.54B, FCF $1.75B. Bull case, bear case, and where we stand.
Sidus Space (SIDU) stock analysis — LizzieSat small-sat constellation, SpaceX Transporter rideshare customer, $100M registered direct offering, FY2025 revenue decline to $3.38M vs $29.5M losses, 448x share count dilution history, NASDAQ compliance risk. Honest microcap assessment for 2026.
Momentus (MNTS) stock analysis — Vigoride water-plasma space tug, SpaceX Transporter rideshare, $25M raise, dilution history, cash burn, going-concern risk, peer comparison vs RKLB/PL/BKSY. Honest microcap assessment for 2026.
Centrus Energy (NYSE-American:LEU) stock analysis — sole US HALEU producer, DOE contracts, advanced reactor fuel supply, NASA space nuclear propulsion. HALEU supply chain monopoly, Daniel Poneman CEO strategy, SMR demand timeline and risks for 2026.
CACI International (NYSE:CACI) stock analysis — signals intelligence, electronic warfare, national security IT, Space Force ground systems. Cleared-personnel moat, ManTech integration, JWCC positioning, risks and valuation for 2026.
Woodward Inc (NASDAQ:WWD) stock analysis — aerospace propulsion controls, LEAP-1A/B fuel systems, GE9X actuators, rocket engine components. TTM revenue $4B (+19%), operating margin expanding to 14.76%, Strong Buy consensus with $437 target.
CAE Inc (NYSE:CAE) stock analysis — global leader in flight simulation and aircrew training, FY2026 revenue CAD 4.91B, transformation plan to 2030, defense backlog, space crew training potential. Buy consensus with $33.24 target.
Teledyne Technologies (TDY) stock analysis — FLIR Systems acquisition, Mars rover cameras, JWST infrared sensors, defense electronics. FY2025 revenue $6.12B (+7.9%), record 18.8% operating margin. Analyst target $728. 2026 outlook.
EchoStar (SATS) stock analysis — AWS-3/AWS-4/H-block spectrum assets, 65MHz sold to SpaceX, Boost Mobile prepaid wireless, Hughesnet satellite broadband. $38B market cap at $131 as of May 2026. Spectrum monetization thesis and real risks.
Hexcel (HXL) supplies carbon fiber prepregs to Boeing 787, Airbus A350, and F-35. Q1 2026 showed 10% sales growth after two flat years. FY2026 guidance calls for $2.0–2.1B revenue. The aerospace cycle is recovering — and HXL has the most operating leverage to capture it.
BlackSky (BKSY) at $51, up 5x from its 52-week low. The Gen-3 constellation expands high-revisit geospatial intelligence — and the government customer pipeline supports 30%+ revenue growth in 2026.
EHang's EH216-S holds the world's first CAAC type certificate for an unmanned passenger autonomous aerial vehicle. Commercial flights run in China, Thailand, and Qatar. But China ADR structure, cash burn, and FAA uncertainty remain hard risks to price.
Mercury Systems (MRCY) went from -7% EBITDA margins and a $14M net loss in FY2024 to FCF of $119M in FY2025. Record Q3 FY26 bookings in missiles, C4I, and space programs mark a genuine operational inflection.
Curtiss-Wright (CW) supplies nuclear propulsion control systems for Columbia-class submarines and is prototyping helium circulators for X-energy's Xe-100 SMR. A steady defense compounder with a growing clean energy option.
Globalstar (GSAT) trades at $84 with a $10.86B market cap following Amazon's $11.6B acquisition announcement. This is now a merger arbitrage situation — here is how to think about the risk-reward.
TransDigm Group (TDG) isn't an aerospace parts maker — it's a capital allocation engine that converts FAA certification renewals into pricing power. 50%+ EBITDA margins, $1.25B debt raise, and 22 Buy ratings in 2026.
Viasat (VSAT) at $85 with $11.6B market cap, up nearly 10x from its 52-week low. The Inmarsat acquisition creates a multi-band satellite powerhouse — if integration succeeds and ViaSat-3 delivers.
Archer Aviation (ACHR) stock analysis 2026. Midnight eVTOL aircraft, Stellantis manufacturing partnership, UAE certification approval, FAA Type Certification progress, $4.98B market cap vs $1.9M revenue. Realistic scenarios.
Intuitive Machines (LUNR) stock analysis 2026. IM-1, IM-2, IM-3 lunar landers, NASA CLPS program, NSNS contract, record Q1 2026 revenue $186.7M, FY2026 guidance $900M-$1B. Valuation at $8.75B market cap explained.
Redwire Corp (RDW) stock analysis 2026. ROSA solar arrays, ISS infrastructure, Artemis II participation, Stalker and Penguin drone contracts with Marines and NATO. TTM revenue $371M, net loss $344M. Is the 5x run sustainable?
Iridium (IRDM) at $51 with a $5.4B market cap. The real thesis isn't the 66 satellites — it's the L-band spectrum license that no competitor can replicate. Project Stardust changes the addressable market.
Spire Global (SPIR) stock analysis 2026. GNSS-RO weather data, maritime AIS, aviation ADS-B from 100+ nanosats. Revenue down 36% TTM but Q1 2026 showed 13% core growth. Valuation, risks, and scenarios.
Planet Labs PBC (PL) stock analysis for 2026. 200+ satellites, FY2026 revenue $308M, AI data platform pivot. Valuation debate, competitive landscape, and three investment scenarios based on verified figures.
Rocket Lab (RKLB) stock hit $150 with an $87B market cap. Electron, Photon, and Neutron form a vertical stack that could redefine its competitive position against SpaceX.
Workday (WDAY) stock analysis 2026: price $124.02, P/E 38x, $9.85B revenue, $174 analyst target, 52% drawdown explained, AI HCM strategy, ServiceNow and Salesforce comparison, and whether the selloff creates an entry.
IBK Industrial Bank of Korea (024110) 2026 analysis for foreign investors. Government 60% stake policy bank structure, SME-focused loan portfolio, NIM sensitivity to Bank of Korea rate cuts, dividend yield analysis, government stake sale scenario, withholding tax 15.4%, KRX access without ADR.
LG Corporation (003550) 2026 analysis for foreign investors. Holding company NAV discount 30–40%, subsidiary breakdown (LG Electronics, LG Chem, LGES, LG Display, LG Innotek, LG H&H), Korea Value-up Program implications, KRX access, 15.4% withholding tax, and no ADR pathway.
Waste Management (WM) stock analysis for 2026: the regulatory moat behind 90+ landfill permits, Stericycle acquisition integration strategy, landfill gas-to-energy and RNG monetization under EPA's Renewable Fuel Standard, RCRA compliance barriers blocking new entrants, and why WM is the most durable compounder in the industrial sector. A practitioner's deep-dive.
Domino's Pizza (DPZ) stock analysis for 2026: the asset-light franchise model generating royalty streams from 20,000+ locations, Hungry For More strategy milestones, the Uber Eats and DoorDash partnership impact on same-store sales, international expansion unit economics, and why this pizza company is really a delivery technology business. An equity analyst's take.
Orion Corporation (271560) 2026 analysis for foreign investors. 60%+ overseas revenue split across China, Russia, and Vietnam. ChocoPie brand moat, RMB and ruble FX exposure, Korea consumer staple premium valuation, KRX-only trading mechanics, withholding tax 15.4%, and bio/food new growth ventures.
Iron Mountain (IRM) stock analysis for 2026: the physical records management moat that generates predictable cash flow, Project Matterhorn's hyperscale data center expansion, AI demand driving colocation growth, AFFO sustainability analysis, and how this unusual REIT straddles two very different businesses. A practitioner's breakdown for income-growth investors.
Kangwon Land (035250) 2026 analysis for foreign investors. Korea's sole casino legal for Korean nationals, Special Act on Coal Mine Area Development, NGCC regulation, COVID recovery trajectory, dividend yield, withholding tax 15.4%, KRX access without ADR, and entry limit policy impact on revenue ceiling.
Allstate (ALL) stock analysis for 2026. We examine the earned premium impact of 25-35% auto rate increases, the California and Florida exposure management strategy, hurricane/wildfire CAT loss seasonality, the combined ratio recovery trajectory, and whether current valuation reflects the underwriting margin inflection.
LG Innotek (KS:011070) 2026 analysis for global investors. iPhone camera module dominance (~70% of revenue), FC-BGA semiconductor substrate expansion for AI chips, automotive components growth, KRW/USD exchange rate leverage, and KRX trading mechanics for non-Korean investors.
Netmarble (251270) 2026 analysis for foreign investors. Coway 25% stake NAV valuation, mobile game revenue cycles, Korean loot box regulations, Jam City and Kabam North America losses, KRX access, withholding tax 15.4%, and no ADR pathway explained.
Welltower (WELL) stock analysis for 2026: the Baby Boomer demand supercycle hitting senior housing, RIDEA operating leverage mechanics, Sunrise and Atria operator economics, FFO/AFFO framework for REIT valuation, occupancy recovery trajectory, and how rising interest rates affect the thesis. A practitioner's REIT analysis for US equity investors.
Samsung C&T (KS:028260) 2026 analysis for global investors. Samsung Group holding structure, 43% stake in Samsung Biologics, Samsung Bioepis 100%, trading/construction/fashion own-business EBITDA, NAV discount mechanics, and KRX trading considerations for non-Korean investors.
Cummins (CMI) stock analysis for 2026: EPA 2027 NOx regulations driving heavy-duty engine replacement demand, Accelera hydrogen and electric powertrain segment strategy, Meritor acquisition integration, Class 8 pre-buy cycle dynamics, and dividend growth history. A practitioner's breakdown for US equity investors.
Kinder Morgan (KMI) stock analysis for 2026. We assess the 70,000-mile natural gas pipeline network, LNG export terminal feed gas dynamics, data center power demand tailwind, the 2016 dividend cut legacy and current balance sheet conservatism, and why this infrastructure toll-collector deserves a second look at ~5% yield.
Aflac (AFL) stock analysis for 2026. We examine the 75% Japan revenue dependency, USD/JPY currency risk mechanics, the US worksite insurance growth engine, 42-year consecutive dividend raise record, investment portfolio interest rate dynamics, and whether the dividend aristocrat valuation is justified.
PNC Financial Services (PNC) stock analysis for 2026. We examine the BBVA USA acquisition integration payoff, treasury management competitive positioning against JPMorgan, NIM trajectory under rate stabilization, CRE credit risks, and the capital return framework for income-oriented equity investors.
Lotte Chemical (KS:011170) 2026 analysis for global investors. NCC ethylene margins, Asia PE/PP spread compression from Chinese overcapacity, EV battery separator film business, KRX trading mechanics, and how foreign investors access this Korean petrochemical cycle play.
Truist Financial (TFC) stock analysis for 2026. We examine how the BB&T-SunTrust merger synergies are materializing, the NIM trajectory in a rate-stabilization environment, CRE exposure risks, capital return capacity, and whether the Southeast franchise justifies a premium over regional bank peers.
Diamondback Energy (NASDAQ: FANG) 2026 analysis. Permian Basin pure-play economics, Endeavor Energy acquisition integration, variable plus base dividend model, WTI breakeven of $30–40, DUC inventory strategy, and how FANG stacks up against Devon, EOG, and Occidental.
CAVA Group (NYSE: CAVA) 2026 analysis covering AUV trajectory, restaurant-level margins, the Chipotle comparison, Mediterranean TAM, competitive threats from Sweetgreen and QSR giants, and whether the post-IPO premium is justified by execution.
Air Products (APD) stock analysis 2026: price $289.60, P/E 30x, $7.24 dividend (2.5% yield), $328 analyst target, NEOM green hydrogen project, Louisiana blue hydrogen, take-or-pay moat, and Linde comparison.
Hilton Worldwide (HLT) stock analysis 2026: price $323.81, market cap $73.7B, P/E 49x, EPS $6.56, dividend $0.60 (0.19%), revenue $5.07B, asset-light model, pipeline growth, analyst target $347.
L3Harris Technologies (LHX) stock analysis 2026: price $313.47, P/E 34x, $22.5B revenue, $5 dividend, $382 analyst target, C6ISR leadership, defense electronics moat, and where it fits in a defense portfolio.
DoorDash stock analysis 2026: price $154, market cap $67.1B, P/E 73x, EPS $2.10, revenue $14.72B, US market dominance, Wolt international expansion, analyst target $245.99 (+60%). Worth the premium?
United Airlines (UAL) stock analysis for 2026: $105.92 price, P/E 9.45x, $60.5B revenue, $130 analyst target, fuel cost dynamics, premium cabin strategy, and how to position in airline stocks.
Warner Bros. Discovery (WBD) stock analysis 2026: $31.00 all-cash acquisition by Paramount Skydance approved by shareholders, ~$110.9B total deal, Q3 2026 close target. At $27, WBD is a merger-arb trade — 15% spread to a confirmed cash price, with break risk toward $9–$12.
Comcast (CMCSA) stock analysis 2026: $25 price, P/E 4.9x, 5.25% dividend yield, Hold consensus with $32.74 analyst target. Broadband vs. FWA competition, Peacock streaming, cord-cutting pressure, and the bull case for multiple re-rating.
The Trade Desk (TTD) stock analysis 2026: price $22.18 down 75% from highs, market cap $10.4B, P/E 25x, revenue $2.97B +15.5%, Kokai migration, CTV growth, analyst target $25.81. Is this the floor?
ONEOK (OKE) stock analysis 2026: Magellan Midstream acquisition integration, NGL and refined products pipeline diversification, 4.73% dividend yield, distribution coverage, P/E 16x, and comparison to Williams Companies and Kinder Morgan.
Sempra (SRE) stock analysis 2026: $91.55 price, 2.87% dividend yield, Buy consensus, $103.71 target, Oncor Texas grid growth, Port Arthur LNG Stage 1, California utility risks, and investment scenarios.
Investment analysis of CJ Logistics (KRX: 000120) for 2026: Korean parcel market share defense against Coupang's internal logistics, US DSC Logistics 4PL expansion, container freight rate exposure, fulfillment automation CAPEX payoff timeline, dawn delivery expansion, and valuation considerations for foreign investors in Korean logistics equities.
After the failed Albertsons merger, Kroger launched a $7.5B share repurchase and is quietly building a high-margin retail media business through Kroger Precision Marketing. Here's whether KR belongs in your 2026 US consumer portfolio.
Philip Morris International's EPS surged 60% in 2025, driven by IQOS Heat-not-burn growth and ZYN nicotine pouches from the Swedish Match acquisition. Here's whether PM's smoke-free transformation makes it a dividend growth stock worth holding in 2026.
Hanmi Science 008930 stock outlook 2026: share price 31,900 KRW, market cap 2.11T KRW, P/E 19.55x, 52-week range 30,900-55,500 KRW, Hanmi Pharmaceutical holding structure, obesity drug HM15275, LAPS platform technology, OS3 pipeline, family governance dispute resolution. Foreign investor access guide.
HD Korea Shipbuilding 009540 stock outlook 2026: share price 405,000 KRW, market cap 29T KRW, revenue 31.18T KRW, Qatar LNGC orders, ammonia dual-fuel ships, LH2 carriers, offshore recovery, 3.08% dividend yield. How international investors can access Korea's shipbuilding giant.
Kraft Heinz (KHC) stock analysis for 2026. We assess the Berkshire Hathaway stake reduction, the $5.76 billion net loss from goodwill impairments, CEO Cahillane's $600M brand reinvestment plan, organic sales decline, GLP-1 headwinds on processed food, and whether the 6.8% dividend is safe.
Deep-dive investment analysis of POSCO Future M (KRX: 003670) for 2026: cathode material capacity expansion to 1 million tonnes, LG Energy Solution and Samsung SDI supply contracts worth ~100 trillion KRW, IRA Foreign Entity of Concern graphite risk, Canada mining investments, and valuation considerations for foreign investors in Korean battery materials stocks.
Hershey (HSY) stock analysis for 2026. We examine the West Africa cocoa supply collapse, SkinnyPop and Dot's Pretzels salty snack diversification, Q1 2026 adjusted EPS of $2.35 beating $2.04 consensus, GLP-1 drug effects on candy sales, and the Mondelez rejected acquisition backstory.
CB Chubb stock outlook 2026: Q1 2026 combined ratio 84%, $328 stock price, $184.95 book value, $127B market cap, Berkshire Hathaway stake, Asia insurance growth via Cigna acquisition, 34 consecutive dividend increases, hard market normalization analysis for global investors.
Investment analysis of Daewoo Engineering and Construction (KRX: 047040) for 2026, covering the Joongheung Group acquisition synergies, Iraq and Nigeria EPC project pipelines, Korean housing project finance (PF) risk exposure, Vietnam new town development, valuation framework, and key risks for foreign investors.
Biogen (BIIB) stock analysis for 2026. We evaluate Leqembi's actual prescription trajectory, the Spinraza revenue decline, Skyclarys rare disease growth, diranersen Phase 2 tau data, and whether the 55% bounce from $121 to $188 is justified.
Devon Energy completed its Coterra Energy merger on May 7, 2026, unlocking $1B in synergies, an $8B buyback, and a 30% dividend hike. Here's how US retail investors should size DVN in a 401k or taxable account in 2026.
Marathon Petroleum blew past Q1 2026 EPS estimates by over 100%, backed by refining margin expansion and MPLX midstream distributions. Here's a US investor's guide to MPC's capital return machine and what it means for 2026 portfolios.
Investment analysis of Korean Air (KRX: 003490) for 2026, covering the completed Asiana Airlines merger (EU/US approval December 2024), mileage program integration, cargo fleet expansion, Boeing 787 and A350 fleet additions, mega-carrier valuation, and key risks for foreign investors accessing Korean aviation equities.
Digital Realty (DLR) stock analysis for 2026. We examine the record $1.8B backlog from AI hyperscale demand, the Northern Virginia power constraint crisis, Blackstone JV structure, Q1 2026 core FFO beat of $2.04 vs $1.94 consensus, and the Singapore expansion play.
KT&G 033780 stock outlook 2026: share price 180,400 KRW, market cap 18.5T KRW, P/E 17.4x, annual dividend 6,000 KRW (3.39% yield), lil HTP PMI global expansion, Korean tobacco market share, Cheong Kwan Jang ginseng growth, share buybacks. How foreign investors access Korea's dominant tobacco company.
TROW T. Rowe Price stock outlook 2026: 40 consecutive years of dividend increases, $1.83T AUM, Q1 2026 net outflows $13.7B, ETF franchise crossing $25B, retirement plan stickiness, 5.1% yield at 10.9x P/E. Is the discount a trap or opportunity?
Dollar General posted 34% net income growth in FY2025 and is deploying AI audio networks across 6,000 stores. With a new CEO arriving in January 2027 and Project Renovate rolling out, here's whether the DG turnaround holds up for US retail investors in 2026.
An investor's deep dive into VICI Properties (VICI) for 2026. We examine the triple-net lease model, Caesars dependency risk, non-gaming diversification with Bowlero and Chelsea Piers, the Golden Entertainment acquisition, and whether the current $28 price offers real value.
A deep-dive investment analysis of Samsung Heavy Industries (KRX: 010140) for 2026, covering LNG carrier backlog, FLNG technology moat, Qatar Energy project exposure, green methanol vessels, valuation after 8 years of losses, and key risks for foreign investors accessing Korean equities.
Williams Companies (WMB) stock analysis 2026: Transco pipeline capacity growth, fee-based midstream model, AI data center gas demand, LNG export tailwinds, 2.75% dividend yield, and how WMB compares to ONEOK and Kinder Morgan.
Reddit stock analysis 2026: current price $144.64, market cap $27.84B, P/E 41x, AI data licensing strategy, ad revenue growth, 52-week range $99-$283, analyst target $224. Buy or wait?
Nasdaq Inc. (NDAQ) stock analysis 2026: Adenza acquisition integration, anti-financial crime software growth, recurring revenue mix shift, $90.88 price vs $106 target, dividend, and how NDAQ compares to ICE and CME Group.
Cheniere Energy (LNG) stock analysis for 2026: $234 price, P/E 34.8x, Strong Buy consensus, $303 analyst target, Corpus Christi Stage 3 expansion, fixed-fee contract model, European and Asian LNG demand.
Apollo Global Management (APO) stock analysis for 2026: private credit market tailwinds, Athene insurance integration, distributable earnings vs GAAP, dividend, valuation, and how APO compares to KKR and Blackstone.
Prudential Financial (PRU) stock analysis 2026: $5.60 annual dividend (5.38% yield), P/E 10.56x, EPS $9.72, TTM revenue $63.29B, analyst consensus Hold with $100.47 target below current price, Japan business risk and PGIM asset management dynamics.
Dexcom (DXCM) stock analysis 2026: $4.82B TTM revenue up 16.2%, EPS +75.5% to $2.34, P/E 30.8x, GLP-1 drug interaction with CGM adoption, Stelo OTC launch, FreeStyle Libre competition, and analyst consensus Strong Buy with $81.64 target.
Boston Scientific (BSX) stock analysis 2026: TTM revenue $20.6B growing 17.4%, P/E 24.2x, 52-week range $52.52–$109.50, analyst target $83.47, WATCHMAN FLX growth, and EP system competitive dynamics.
Thermo Fisher Scientific (TMO) stock analysis for 2026: $45.2B TTM revenue, P/E 24.6x, CDMO recovery cycle, NIH budget headwinds, analyst target $611, and what the 30% drop from highs actually means for investors.
Automatic Data Processing (ADP) 2026 stock analysis: 49-year dividend growth streak nearing Dividend King status, float revenue sensitivity to Fed rate cuts, AI-driven HR competition, and tax-efficient placement in Roth IRA and 401(k) accounts.
American International Group (AIG) completed one of corporate America's most dramatic restructurings — from a $182B government bailout in 2008 to a focused global P&C insurer under CEO Peter Zaffino. This 2026 outlook covers combined ratio improvement, Corebridge Financial separation, cyber insurance growth, and how to evaluate AIG in a Roth IRA or taxable account.
CME Group (CME) operates the world's largest derivatives marketplace — interest rates, agriculture, energy, metals, and FX. We analyze ADV trends, clearing moat, BrokerTec/EBS, competitive dynamics with ICE, and the 2026 investment case.
Datadog (DDOG) dominates cloud observability with a unified platform spanning monitoring, APM, security, and now AI workload management. With GPU Monitoring launched in April 2026, FedRAMP High certification achieved, and Bits AI agents rolling out, DDOG is positioned at the intersection of AI infrastructure and SaaS compounding. This analysis covers NRR mechanics, platform expansion, bull and bear scenarios, and Roth IRA vs. taxable account considerations.
Dell Technologies (DELL) delivered FY26 revenue of $113.5B (+19%) and adjusted free cash flow of $11.5B (+271%), validating its AI server thesis through PowerEdge XE9680 demand and the NVIDIA partnership. This analysis covers ISG vs. CSG segment dynamics, the bull and bear cases, dividend tax strategy, and what to monitor in the next 10-Q.
Freeport-McMoRan (FCX) 2026 analysis: Grasberg operating rights extension, copper super-cycle thesis driven by EVs and AI data center infrastructure, gold byproduct leverage, variable dividend policy, and portfolio positioning for US commodity investors.
Detailed analysis of GD (General Dynamics) stock for 2026: Columbia-class and Virginia-class submarine programs, Gulfstream business jets, GDIT defense IT, backlog fundamentals, and the case for defense sector investors.
Comprehensive analysis of GEV (GE Vernova) stock for 2026: gas turbine installed base, onshore/offshore wind, Grid Solutions, nuclear SMR optionality, AI data center power demand, and the investment case for energy transition investors.
Huntington Ingalls Industries (HII) holds a structural monopoly on nuclear-powered aircraft carrier construction at Newport News Shipbuilding. With Ingalls Shipbuilding, Mission Technologies, and a multi-billion-dollar backlog, HII is the backbone of US naval power.
Deep-dive into ICE (Intercontinental Exchange) stock for 2026: NYSE operations, Black Knight mortgage tech, fixed-income data infrastructure, energy futures, and the bull/bear case for long-term investors.
Moody's Corporation (MCO) holds NRSRO status and earns through credit ratings (MIS) and analytics SaaS (Moody's Analytics). We analyze the duopoly moat, rate cycle sensitivity, ESG data expansion, and MCO's 2026 investment case.
MongoDB (MDB) is the dominant NoSQL document database serving 50,000+ customers including 70% of the Fortune 100, with MongoDB Atlas as its managed cloud growth engine and Atlas Vector Search as its AI/RAG positioning. This analysis covers the document DB vs. relational DB debate, NRR mechanics, vector database competition, bull and bear scenarios, and tax-efficient account placement for US investors.
Newmont (NEM) is the world's largest gold miner by market cap, with a five-continent portfolio and a disciplined AISC framework. This analysis covers the bull and bear thesis, portfolio positioning, tax treatment in Roth and 401k accounts, and what to watch in the next 10-Q.
Northrop Grumman (NOC) 2026 analysis: B-21 Raider stealth bomber sole-source production, space and missile defense growth, US defense budget dynamics, dividend growth record, and portfolio positioning for US investors in defense equities.
Progressive Corporation (PGR) is a top-3 US auto insurer with Snapshot telematics, dual direct-agency channels, and a hard market track record of outperforming peers on combined ratio. We analyze the 2026 setup for PGR investors.
Phillips 66 (PSX) operates refining, midstream (DCP merger), chemicals (CPChem JV with Chevron), and lubricants. We analyze crack spread exposure, WCS-Brent differentials, DCP synergies, and the 2026 investment case for PSX investors.
Southern Company (SO) 2026 analysis: regulated utility moat in the US Southeast, Vogtle Units 3&4 nuclear assets, AI data center electricity demand boom, 20+ year dividend growth record, and rate-sensitive return framework for US investors.
Comprehensive analysis of SPGI (S&P Global) stock for 2026: credit ratings moat, S&P 500 index licensing, Platts commodity data, IHS Markit integration, and what drives EPS growth for long-term investors.
In-depth analysis of TRV (Travelers Companies) stock for 2026: combined ratio fundamentals, hard market pricing, catastrophe reserves, dividend growth history, and the bull/bear case for US P&C insurance investors.
Texas Instruments (TXN) 2026 stock outlook: 22-year dividend growth streak, FCF-per-share capital return philosophy, 300mm fab investment thesis, and analog semiconductor cycle recovery. Tax-efficient placement strategies for US investors.
SMR NuScale Power stock outlook 2026: 77 MWe NPM NRC design certification achieved May 2025, UAMPS CFPP cancellation lessons, RoPower Romania February 2026 investment approval, ENTRA1-TVA non-binding 6 GW collaboration, dilution risk and zero revenue analysis. IRA Section 45U nuclear tax credit angle.
VRTX Vertex Pharmaceuticals stock outlook 2026. Trikafta $2.35B quarterly revenue, Journavx non-opioid pain FDA approved January 30 2025, Casgevy gene therapy 9 countries, inaxaplin APOL1 kidney interim data expected early 2027. Three-scenario valuation for US investors.
Synopsys (SNPS) closed the $34.9B Ansys acquisition on July 17, 2025. Q1 FY2026 revenue hit $2.41B (+65.5% YoY). EDA leadership meets simulation dominance—but $10B in new debt and integration risk are real. Here's the full analysis for 2026.
CRDO Credo Technology FY2026 Q3 revenue hit $407M (+201% YoY) with 68.5% gross margin. This 2026 outlook covers AEC technology moat, 87% customer concentration risk, Microsoft partnership, and Buy/Hold/Avoid scenarios for US investors.
VRT Vertiv Holdings posted Q1 2026 revenue of $2.65B (+30% YoY), diluted EPS of $0.99, and holds a $15B order backlog — making it one of the most visible-revenue AI infrastructure plays available to US investors today.
OKLO Oklo stock outlook 2026: Aurora powerhouse 15-75 MWe specs, NRC COLA resubmission timeline after 2022 denial, DOE Idaho National Lab site permit, Meta/Switch data center LOI pipeline, HALEU fuel supply constraints. Binary regulatory bet analyzed.
ALAB Astera Labs posted Q1 2026 revenue of $308.4M (+93% YoY) with a 76.3% gross margin and 20.1% operating margin. Here's why this AI fabric connectivity chipmaker deserves a place in your watchlist — and where the real risks lie.
ANET Arista Networks 2026 outlook: Q1 2026 revenue of $2.71B (+35% YoY), Non-GAAP operating margin 47.8%, Q2 guide of $2.8B. Covers EOS software moat, NVIDIA Spectrum-X threat, Meta and Microsoft concentration risk, and Buy/Hold scenarios for US investors.
BWX Technologies (BWXT) stock outlook 2026: verified data on the $1.4B naval nuclear propulsion contracts (May 2026), Columbia-class SSBN and Virginia-class SSN monopoly supply, Project Pele microreactor ($300M DoD contract), medical radioisotopes business, FY2025 revenue $3.2B, and three price scenarios.
Dell Technologies (DELL) hit $113.5B in FY2026 revenue (+19% YoY) driven by AI-optimized server demand. But gross margins compressed to 20.0%—down from 23.8% in FY2024. Here's what that trade-off means for DELL investors in 2026.
REGN Regeneron stock outlook 2026. Dupixent global sales hit $4.9B in Q1 2026 (+33%), Eylea HD biosimilar transition, Lynozyfic FDA approval July 2025, Libtayo oncology surge, three-scenario valuation for US investors.
Moderna (MRNA) stock outlook 2026: $7.5B cash runway, mRESVIA RSV launch, intismeran autogene Phase 3 with Merck, $1.94B FY2025 revenue, analyst Hold consensus at $36.82 target. Full pipeline, 3 price scenarios, and honest risk assessment for US investors.
Constellation Energy (CEG) stock outlook 2026: verified data on the Three Mile Island/Crane Clean Energy Center restart, Microsoft 20-year PPA, Calpine $26.6B acquisition (closed Jan 7, 2026), Section 45U nuclear PTC, 19GW+ fleet economics, and price scenarios.
Madrigal Pharmaceuticals (MDGL) 2026 stock analysis: Rezdiffra revenue trajectory reaching $958M in FY2025 and $311M in Q1 2026, US payer coverage progress, GLP-1 competition dynamics, confirmatory trial risk, and acquisition thesis.
Monolithic Power Systems (MPWR) posted $804M in Q1 2026 revenue (+26% YoY) with Enterprise Data surging 97.7%. This analysis covers MPWR's fabless model, TSMC risk, NVIDIA concentration, valuation, and three investment scenarios for 2026.
CCJ Cameco stock outlook 2026: Q1 2026 earnings analysis, McArthur River/Key Lake and Cigar Lake production, Inkai JV Kazakhstan supply risk, Westinghouse 49% stake contribution, spot vs long-term uranium contract strategy. IRA Section 45U tailwinds.
Vistra Corp (VST) stock outlook for 2026: Energy Harbor acquisition impact, Comanche Peak nuclear PPA strategy, AI hyperscaler long-term power deals, IRA nuclear PTC tailwinds, and three price scenarios with key financial data.
Gilead Sciences (GILD) stock outlook 2026: Biktarvy $3.4B quarterly, Yeztugo $166M debut, anito-cel CAR-T PDUFA Dec 23, 2026, 2.46% dividend yield, analyst target $152. Full pipeline, risks, and 3 price scenarios for US investors.
AstraZeneca (AZN) 2026 stock outlook covering Tagrisso, Enhertu, Datroway ADC pipeline, Farxiga CVRM growth, China VBP risk, and US Medicare price negotiation impact. Revenue data through Q1 2026.
NVO Novo Nordisk stock outlook for 2026. Wegovy and Ozempic franchise vs Eli Lilly competition, CagriSema REDEFINE trial setback, IRA Medicare drug pricing risk, amycretin pipeline, and three-scenario valuation analysis for US investors.
Lululemon Athletica (LULU) stock analysis for 2026 covering Power of Three ×2 strategy progress, the Mirror acquisition and exit lessons, men's line growth, China international expansion, and the competitive threat from Alo Yoga and Vuori.
KLA Corporation (KLAC) stock analysis for 2026 covering its near-monopoly in optical wafer inspection, why semiconductor scaling structurally increases process control demand, CEO transition impact, China export risks, and the case for holding KLAC in a long-term portfolio.
US Bancorp stock analysis for 2026: fifth-largest US commercial bank, three-segment business with Elavon payment services, MUFG Union Bank acquisition integration, CEO Gunjan Kedia strategy, dividend history, and 401(k)/Roth IRA suitability.
Capital One stock analysis for 2026: Discover Financial acquisition complete, becoming America's largest credit card lender by loans, founder-CEO Richard Fairbank's data model, consumer credit cycle risks, and tax treatment for US investors.
Danaher stock analysis for 2026: bioprocessing destocking cycle resolution, Cytiva and Pall recovery thesis, Abcam acquisition integration, Cepheid post-pandemic diagnostic growth, Danaher Business System advantage, and valuation framework for the recovery story.
Enbridge (ENB) stock analysis for 2026: the $14B Dominion gas utility acquisition, Mainline crude oil pipeline dominance, Canadian midstream structure (not a US MLP), dividend growth history, 401(k) vs Roth IRA tax treatment for Canadian dividends, and three investment scenarios.
Prologis (NYSE: PLD) stock analysis for 2026 covering the Duke Realty integration, data center campus pivot, embedded rent growth from mark-to-market lease rollovers, REIT tax treatment in IRAs, and the e-commerce vs. AI demand thesis for industrial real estate.
Lam Research (LRCX) stock analysis for 2026 covering the NAND and DRAM capex cycle recovery, HBM manufacturing complexity driving etch and deposition demand, CSBG recurring revenue, and the structural WFE oligopoly thesis.
Charles Schwab stock analysis for 2026: TD Ameritrade integration complete, 2023 cash sorting episode resolved, net interest income recovery trajectory, Rick Wurster CEO strategy, and what SCHW means for a US investor's Roth IRA or taxable account.
Intuitive Surgical stock analysis for 2026: da Vinci 5 FDA clearance and upgrade cycle implications, razor-and-blade model economics, Ion lung biopsy platform growth, competitive threats from Medtronic Hugo and J&J Ottava, and valuation framework for growth investors.
3M Company (MMM) stock analysis for 2026: the April 2024 Solventum healthcare spinoff, the $12.5B PFAS water utilities settlement, the $6B Combat Arms earplug settlement, CEO William Brown's restructuring agenda, and the Dividend King narrative after the dividend cut.
Realty Income (NYSE: O) stock analysis for 2026 covering 650+ consecutive monthly dividends, Dividend Aristocrat status, VEREIT and Spirit Realty acquisitions, UK expansion, REIT tax treatment in IRAs, and the interest rate sensitivity thesis.
Analog Devices (ADI) stock analysis for 2026 covering industrial semiconductor cycle recovery, Linear Technology and Maxim Integrated merger synergies, automotive BMS opportunity, and suitability for long-term dividend-growth portfolios.
Morgan Stanley stock analysis for 2026: three-segment business model, E*TRADE and Eaton Vance acquisition impact, Ted Pick CEO strategy, Fed rate sensitivity, and how MS fits a US investor's 401(k) or taxable portfolio.
Delta Air Lines (DAL) stock analysis for 2026: AmEx loyalty revenue stream, SkyMiles program valuation, Delta One premium cabin strategy, hub dominance at Atlanta ATL, cyclical risk factors, and 401(k) suitability for US investors.
HCA Healthcare (NYSE: HCA) stock analysis for 2026 covering Sunbelt population growth tailwinds, ambulatory surgery center expansion, GLP-1 long-term impact on surgical volumes, capital allocation, and bull/bear scenarios for US investors.
Mondelez International stock analysis for 2026: Oreo, Cadbury, Ritz brand portfolio, the direct GLP-1 threat to snack demand, Clif Bar and Ricolino acquisition impacts, cocoa cost pressure, and emerging market growth as the offsetting thesis.
American Tower (AMT) stock analysis for 2026: global tower footprint of ~220,000 sites, CoreSite data center acquisition, Big-3 US telco tenant concentration, REIT tax treatment for 401k and IRA investors, and three investment scenarios.
Cigna Group (NYSE: CI) stock analysis for 2026 covering the Evernorth PBM strategy, Medicare Advantage divestiture to HCSC, regulatory risk from FTC, GLP-1 drug cost exposure, and bull/bear scenarios for US investors.
Coca-Cola stock analysis for 2026 covering its 62-year dividend streak, GLP-1 weight-loss drug threats to beverage demand, asset-light bottling model, segment breakdown, and Roth IRA suitability for US income investors.
Análisis de SoFi Technologies (SOFI) para 2026: primer año de beneficios, desglose de los tres segmentos (Préstamos, Plataforma Tecnológica, Servicios Financieros), ventaja competitiva de Galileo y escenarios de precio a 12 meses con datos verificados.
Deere & Company (DE) 2026 analysis: FY2025 earnings trough, precision ag subscription model, USDA farm income trends, right-to-repair settlement, and 12-month bull/base/bear price targets. Compared with CAT for 401k and taxable account investors.
Riot Platforms (NASDAQ: RIOT) stock analysis for 2026. ERCOT demand-response monetization, 38.5 EH/s hashrate, 18,005 BTC treasury, Corsicana AI data center, AMD lease ramp, bull/base/bear scenarios, and Form 1040 tax reporting.
Análisis de Block Inc. (SQ) para 2026: ecosistema Square para comerciantes, monetización de Cash App, reservas de ~8.000 BTC, integración Afterpay BNPL y escenarios de precio a 12 meses con datos financieros verificados.
SoFi Technologies (SOFI) 2026 analysis: first profitable year data, three-segment breakdown (Lending, Tech Platform, Financial Services), Galileo B2B moat, and 12-month price scenarios based on verified financials.
Block (SQ) analysis for 2026: Square seller ecosystem, Cash App monetization ladder, ~8,000 BTC treasury, Afterpay BNPL integration, and 12-month price scenarios with verified financials.
Blackstone (BX) 2026 stock analysis: FRE growth trajectory, BREIT recovery, AI data center tailwinds, variable dividend mechanics, and 12-month bull/base/bear targets. Compared with Apollo and KKR for 401k and taxable account investors.
MARA Holdings (NASDAQ: MARA) stock analysis for 2026. Covers 66.4 EH/s hashrate, 53,822 BTC treasury, Long Ridge Energy acquisition, AI/HPC pivot, bull/base/bear scenarios, and Form 1040 Bitcoin tax reporting for US investors.
Block(SQ)의 Square·Cash App 이중 생태계, 비트코인 재무 전략, Afterpay BNPL, 2026년 실적 가이던스 기반 주가 시나리오를 분석합니다. Jack Dorsey 비전과 한국 투자자 세금 가이드 포함.
Abbott Laboratories (ABT) stock outlook 2026. FreeStyle Libre CGM dominance, 4-segment diversification, 52-year dividend streak, 50% analyst upside, and price target scenarios for US investors.
Verizon 2026 stock analysis: Frontier Communications acquisition debt impact, C-band 5G build, postpaid turnaround, and whether the 6% dividend yield is genuinely safe.
Merck (MRK) 2026 stock analysis: Keytruda's 2028 patent cliff, Winrevair growth, $112.30 price, 3% dividend, analyst targets, and US investor tax strategy.
American Express AXP stock analysis 2026: closed-loop network advantage vs Visa/Mastercard, Millennial/Gen Z card growth, Centurion Bank deposits, Buffett's 21% stake, dividend trajectory, and credit write-off risk at peak cycle.
AbbVie (ABBV) stock outlook 2026. Humira biosimilar erosion absorbed, Skyrizi+Rinvoq now exceeding peak Humira combined, 3.41% dividend yield, 12-month price target scenarios analyzed.
UPS stock analysis for 2026: Teamsters contract cost trajectory, USPS contract loss, Amazon volume pullback, FedEx competition, and the dividend sustainability debate. Bull/base/bear scenarios with verified financials.
AT&T stock analysis for 2026: post-WarnerMedia FCF recovery, 5G fiber expansion, debt deleveraging, and whether the $1.11 dividend can hold. Analyst target $30.53.
Pfizer (PFE) 2026 stock analysis: $26.48 price, 6.5% dividend yield, Seagen pipeline, patent cliff risks, and 12-month price targets for US investors.
Occidental Petroleum (OXY) investment analysis for 2026. OxyChem sold to Berkshire Hathaway for $9.7B (closed Jan 2026), CrownRock Permian integration, STRATOS DAC commercialization, Berkshire 26.6% stake, and valuation without the distorted TTM P/E.
Pearl Abyss' Crimson Desert surpassed 5 million copies sold within its first month after launching March 19, 2026. With Black Desert revenues up 34% in 2025 and DokeV in the pipeline, here's the investment case for Korea's most watched gaming stock.
ExxonMobil stock analysis 2026: FY2024 revenue of $339B, Pioneer acquisition integration, Guyana offshore expansion, Permian growth, CCS and hydrogen investments, $4.12 dividend, and XLE comparison.
Hanjin Kal controls Korean Air post-Asiana acquisition with a KRW 26 trillion combined revenue target for 2026. A live governance dispute with Hoban Construction and full merger integration make this the most event-driven KOSPI stock of 2026.
RTX Corporation stock analysis 2026: Pratt & Whitney GTF powder metal recall recovery costs, record backlog growth, Q1 2026 double-digit organic sales, dividend profile, and ITA ETF comparison.
Samsung Fire & Marine Insurance posted KRW 1.82 trillion net profit in 2025 with a K-ICS ratio of 277% and 61.9% shareholder return. Here's the investment case for Korea's dominant P&C insurer in 2026.
Lockheed Martin stock analysis 2026: FY2024 revenue of $71B, F-35 program status, Sentinel ICBM contract, hypersonics pipeline, $13.80 dividend, and comparison to ITA aerospace ETF.
SK Telecom's 2025 operating profit fell 41% after Korea's largest-ever cybersecurity breach. We examine the AI recovery plan, SKM ADR mechanics, the SK Square/SK Hynix structure most investors get wrong, and whether the 2026 dividend holds.
Roblox stock analysis 2026: FY2024 revenue of $3.6B, daily active users, 17+ content expansion, immersive advertising launch, child safety lawsuits, AI moderation, and the bookings guidance cut.
KT Corp's operating profit surged 205% to KRW 2.47 trillion in 2025 on KRW 28.24 trillion revenue. The AICT pivot, KRW 2,400 DPS dividend, and Gasan AI data center make this a compelling yield-plus-growth KOSPI play.
PayPal stock analysis 2026: CEO Alex Chriss's turnaround strategy, branded checkout vs. Braintree dynamics, PYUSD stablecoin, FY2024 financials, P/E of 8.7x, and fintech ETF alternatives.
Hyundai Mobis posted record 2025 revenue of KRW 61.1 trillion and operating profit of KRW 3.36 trillion. Here's what the electrification pivot, R&D ramp, and governance reform mean for investors.
Johnson & Johnson stock analysis 2026: post-Kenvue spin-off financials, talc litigation resolution path, MedTech vs Innovative Medicine segment dynamics, dividend history, and XLV comparison.
Procter & Gamble stock analysis for 2026 covering its 67+ year dividend streak, GLP-1 weight-loss drug implications for consumer staples, FY2024 financials, and Roth IRA suitability.
LG Electronics posted record Q1 2026 revenue of KRW 23.7 trillion with a 33% operating profit surge. Discover what the VS, HVAC, and AI home strategy mean for foreign investors this year.
DGRW weights holdings by projected dividend stream × quality screens (ROE/ROA), not market cap. With NVDA, AAPL, and MSFT as top holdings, it blends growth tech and dividend growth into one fund. Full analysis: expense ratio 0.28%, AUM ~$16B, tax treatment, and portfolio fit.
A thorough analysis of DIVO, Amplify's actively managed blue-chip dividend ETF with a tactical covered-call overlay: how Capital Wealth Planning selects 25-30 stocks, manages the 5-15% call overlay, handles ROC distributions, and how it compares to SCHD, JEPI, and QYLD for income investors.
A deep dive into Fidelity's FDVV ETF: how the three-factor index blends dividend yield, dividend growth, and payout consistency across ~100 stocks, its 0.16% expense ratio, tech-inclusive holdings, and where it fits alongside HDV, SCHD, and VYM in an income portfolio.
Comparing fixed indexed annuities (FIA) and variable annuities (VA): participation rate caps, M&E fees, GLWB/GMIB riders, surrender charge schedules, taxation, and how both stack up against low-cost direct investing in 2026.
A thorough analysis of BlackRock's HDV ETF: Morningstar Dividend Yield Focus Index methodology, 0.08% expense ratio, energy-heavy portfolio, qualified dividends, and how to position it in a taxable account or IRA alongside SCHD and VYM.
A practitioner's analysis of PFF (iShares Preferred & Income Securities ETF): how 456 preferred securities deliver ~6.34% monthly income, why PFF behaves like a long-duration bond, and how to deploy it in a tax-aware income portfolio.
An expert look at RYLD (Global X Russell 2000 Covered Call ETF): how ATM call writing on small-caps produces ~12% distribution yield, why NAV erosion is the real cost, and how to fit RYLD into a tax-aware income portfolio.
SCHY tracks the Dow Jones International Dividend 100 Index — 134 ex-US developed-market dividend payers including TotalEnergies, Allianz, BHP, and GSK. Expense ratio 0.08%, yield ~3.4%, foreign tax credit mechanics, and how it pairs with SCHD for global dividend coverage.
SDY (SPDR S&P Dividend ETF) tracks the S&P High Yield Dividend Aristocrats Index, requiring 20+ consecutive years of dividend increases across the S&P Composite 1500 — not 25 years like NOBL. We examine the yield-weighted methodology, how it compares to SCHD and NOBL, whether the 0.35% expense ratio is justified, and who should actually own it.
SPYD (SPDR Portfolio S&P 500 High Dividend ETF) tracks the S&P 500 High Dividend Index, holding the top 80 dividend-yielding S&P 500 stocks at just 0.07% expense ratio. We break down who should own it, who should avoid it, and how it fits a retirement income portfolio alongside SCHD and VYM.
VIG (Vanguard Dividend Appreciation ETF) tracks the S&P U.S. Dividend Growers Index, holding only companies with 10+ consecutive years of dividend increases at a 0.06% expense ratio. We examine whether VIG's low starting yield and growth-first philosophy beats SCHD, SPYD, and the total market for long-term US investors.
Rivian (RIVN) 2026 investment analysis: first annual gross profit $144M, 42,247 deliveries, R2 Q2 2026 launch, Amazon 30,000+ EDVs, VW $1B investment, 62-67K delivery guide, bull and bear scenarios.
Elevance Health (ELV) 2026 investment analysis: 45.4M members, 86.8% MLR, $18B Carelon revenue, MA star ratings, IRA Part D $2,000 OOP cap, bull and bear scenarios vs. UNH, HUM, CI.
NextEra Energy (NEE) 2026 investment analysis: FPL vs. NEER segment valuation, IRA tax credits, 33 GW backlog, 8%+ EPS CAGR guidance, dividend aristocrat path, bull and bear scenarios.
Hyundai Rotem (KRX: 064350) 2026 investment analysis. K2 Poland Phase 2 $6.5B contract, Peru 54-tank order, K2PL licensed production, Morocco $1.6B rail contract, dual defense-rail business model, book-to-bill framework, peer comparison vs Rheinmetall and GDLS, key risk triggers.
BlackRock (BLK) 2026 stock outlook: near $14T AUM, iShares fee economics by bps, Aladdin SaaS recurring revenue, BUIDL tokenized fund on Ethereum, GIP acquisition, vs Vanguard and State Street.
NCSoft (036570) stock analysis 2026: first operating loss in 26 years, Throne and Liberty Western expansion via Amazon, Aion 2 pipeline, AI gaming development, and Krafton vs Netmarble comparison.
Amorepacific (090430) 2026 stock analysis: Sulwhasoo China comeback, Laneige US Sephora growth, daigou duty-free channel recovery, COSRX synergy, LG Household & Shiseido comparison, and KRX cosmetics stock guide for global investors.
LIG Nex1 (KRX: 079550) 2026 investment analysis. Cheongung M-SAM exports to Middle East, L-SAM development, Haesong anti-ship missiles, book-to-bill framework, FMS vs DCS export mechanics, peer comparison with Raytheon and MBDA, and risk triggers for global investors.
Meritz Financial Group (KRX: 138040) 2026 outlook: Korea's highest-ROE holding company, K-ICS ratio, share buyback strategy, IFRS 17 CSM analysis, vs Samsung Life and DB Insurance.
Doosan Fuel Cell (336260) 2026 analysis: PAFC M400 vs SOFC technology, South Korea's CHPS clean hydrogen power policy, IRA Section 45V tax credit, Bloom Energy comparison, HyAxiom US expansion, and KRX hydrogen stock guide.
Hanmi Pharmaceutical (128940) 2026 outlook: GLP-1 obesity pipeline, efpeglenatide Phase 3, MSD license milestones, Lapscovery platform, IFRS R&D capitalization risk, and KRX investing guide for global investors.
Korea Aerospace Industries (KAI, KRX: 047810) 2026 investment analysis. KF-21 production contract, FA-50 export wins across NATO and ASEAN, MRO revenue stream, book-to-bill framework, peer comparison vs Lockheed and Embraer, and key risk triggers for global investors.
Applied Materials 2026 analysis: 2nm/advanced node equipment share, HBM capex demand, China export control exposure, WFE TAM from SEMI World Fab Forecast, and how US investors should think about semiconductor equipment.
Citigroup 2026 analysis: Jane Fraser's five-segment reorganization, ROTCE target of 11–12%, CET1 ratio, Basel III endgame, CCAR stress test results, and what US investors should know about positioning in C.
Amgen 2026 analysis: MariTide GLP-1 Phase 3 inflection, Horizon Therapeutics integration, biosimilar erosion of Prolia and Enbrel, CMS drug price negotiation risk, and how US investors should position.
ServiceNow 2026 analysis: Now Assist GenAI ARPU expansion, cRPO visibility, ITSM/HRSD/ITOM platform moat, valuation risk, and how US investors should think about holding NOW.
CSCO 2026 outlook after the Splunk acquisition: AI ethernet demand, security observability integration, dividend growth trajectory, and how US investors should position.
EcoPro BM (247540) 2026 stock analysis: NCM cathode material for Samsung SDI and SK On, IRA AMPC Section 45X credit extension, Ford and VW EV cycle recovery, LFP competition risk, and how US investors can access Korean battery material stocks.
Hotel Shilla (008770) 2026 analysis: duty-free segment recovery from China daigou normalization, Incheon Airport lease renegotiation, Korea Tourism Organization visitor statistics, China GACC data, and US investor access via EWY.
CJ CheilJedang (097950) 2026 analysis: Bibigo frozen dumpling US market share leadership, Schwan's acquisition leverage, food vs bio segment GP margin decomposition, amino acid cycle risk, and US investor access via EWY or direct KRX.
HD Hyundai Heavy Industries (329180) 2026 analysis: LNG carrier supercycle, ammonia and methanol dual-fuel vessel technology, IMO 2030 regulations, backlog comparison vs Samsung Heavy and Hanwha Ocean, and how US investors access Korean shipbuilding stocks.
Starbucks (SBUX) 2026 analysis: Brian Niccol's 'Back to Starbucks' plan mechanics, US SSSG transaction-count recovery, China Luckin structural competition, NLRB labor relations cost structure, and FCF-to-dividend coverage ratio. Position: gradually constructive with specific SSSG triggers.
Hanwha Aerospace (012450) 2026 stock analysis: K9 self-propelled howitzer Poland and Egypt follow-on orders, Cheongung II missile exports, Nuri rocket, book-to-bill ratio above 2.0x, and how US investors can access Korean defense stocks.
Nike (NKE) 2026 analysis: DTC strategy reversal and gross margin dilution, wholesale channel restoration, Hoka and On Running competitive encroachment, China SSSG recovery pace under guochao pressure, and inventory normalization. Position: watchful/neutral with SSSG transaction-count triggers.
SK Innovation (096770) 2026 investment analysis covering SK On battery division losses, refining crack spread cycles, the post-merger SK E&S LNG and hydrogen portfolio, and US investor access via EWY or direct KRX trading.
Boeing (BA) 2026 analysis: FAA Order 8100.16 production rate constraints on 737 MAX, 787 delivery normalization and FCF recovery, BDS fixed-price contract forward losses, backlog conversion timeline, and book-to-bill trajectory. Position: gradually constructive once delivery trend confirms with specific triggers.
Doosan Bobcat (241560) 2026 investment outlook covering North American compact equipment leadership, US housing starts sensitivity, post-merger governance clarity after the failed Doosan Enerbility combination, EPA Tier 4 Final compliance costs, and EWY access for US investors.
KB Financial Group (105560) 2026 stock analysis for US investors: CEO Yang Jong-hee's digital strategy, NIM and CIR dual improvement, real estate PF provisioning cycle, ADR access, and Korean dividend withholding tax.
General Motors (GM) 2026 analysis: Cruise robotaxi scale-back cash benefit vs strategic optionality lost, Ultium battery factory utilization ramp, China SAIC-GM equity income erosion, and dividend + buyback shareholder return case. Position: watchful/neutral with dual triggers for upgrade.
Alteogen (196170) 2026 outlook through the lens of ALT-B4 subcutaneous delivery platform, MSD Keytruda SC milestone structure, competition with Halozyme ENHANZE, and access options for US investors via EWY or direct KRX trading.
Ford (F) 2026 analysis: F-150 Lightning demand slowdown, Ford Pro software subscription story, ICE cash cow durability under EPA CAFE, UAW contract cost structure, and IRA § 30D implications for US investors. Position: cautious/hold with clear buy triggers.
Shinhan Financial Group (055550) 2026 outlook for US investors: treasury share cancellation progress, 50% CCR policy, NIM vs KB Financial, PF loan normalization, and how to access Korean bank stocks from the US.
Chevron (CVX) 2026 investment analysis — ICC arbitration timeline and Stabroek Block scenarios, Permian Wolfcamp/Bone Spring cost structure, Tengiz FGP ramp, Australia and Israel LNG, free-cash-flow breakeven Brent, capital return program, and how the Hess merger outcome reshapes the XOM vs CVX comparison.
Caterpillar (CAT) 2026 stock outlook: Energy & Transportation segment as a data-center backup power play, copper mining capex cycle, IIJA infrastructure tailwind, dealer inventory normalization, autonomous mining trucks, and capital return track record. Segment-level analysis for long-term investors.
BMY 2026 deep-dive: Eliquis IRA Medicare pricing impact, Karuna/Cobenfy commercial ramp, RayzeBio radiopharma bet, Opdivo franchise against Keytruda, Mirati KRAS position, dividend sustainability with heavy M&A debt, and patent cliff math. Written for US and global investors.
Goldman Sachs (GS) 2026 stock outlook: M&A and IPO cycle recovery, Asset & Wealth Management expansion, consumer banking exit (Marcus, Apple Card), capital return capacity, and how GS compares to Morgan Stanley, JPMorgan, and boutiques like Evercore and Lazard.
Wells Fargo (WFC) 2026 stock analysis: the Federal Reserve's $1.95T asset cap and release timeline, Charlie Scharf restructuring progress, Wealth & Investment Management growth, NII sensitivity to rate cuts, CCAR capital return capacity, and how WFC stacks up against JPM, BAC, and C.
Samsung Biologics (KRX: 207940) 2026 investment analysis for global investors: Plant 5 operating leverage, BIOSECURE Act tailwinds vs WuXi Biologics, ADC CDMO entry, Samsung Bioepis IPO scenario, biosimilar pipeline (Pyzchiva, Hadlima), and CDMO peer comparison with Lonza, WuXi, FUJIFILM Diosynth.
HMM (KRX 011200) 2026 outlook for global investors: SCFI freight rate dynamics, Red Sea rerouting impact, Premier Alliance positioning vs Gemini Cooperation, Korean government privatization timeline, methanol dual-fuel newbuilds, and how HMM compares to MSC, Maersk, CMA CGM, and COSCO in the new alliance landscape.
Krafton (259960) 2026 stock analysis: PUBG single-IP concentration risk, inZOI early access launch traction, BGMI India regulatory exposure, shareholder return program, and how Krafton stacks up against Take-Two, EA, NetEase, and Tencent on gaming-stock valuation.
KakaoBank (KRX 323410) 2026 outlook for international investors: business model, Kakao conglomerate governance risk, NIM compression, Indonesia Superbank stake, competitive moat vs Toss Bank and K Bank, and how non-Korean investors access KRX 323410 through HSBC or Interactive Brokers.
Samsung SDI (KRX 006400) 2026 stock outlook: Hungary factory utilization, US IRA AMPC credits via GM and Stellantis JVs, 26700 cylindrical cell ramp, ESS market recovery, and how SDI stacks up against CATL and LG Energy Solution in the global battery race.
Merck (MRK) 2026 stock outlook: Keytruda patent cliff preparation ahead of 2028 expiry, subcutaneous formulation strategy, IRA drug pricing negotiation impact, next-generation oncology pipeline depth, dividend growth sustainability, and whether MRK fits in an income or growth portfolio.
T-Mobile (TMUS) 2026 stock outlook: what comes after Sprint synergies run out, the 5G subscriber growth ceiling, fixed wireless access (FWA) as an internet service lever, share buyback capacity, and whether TMUS fits in a US growth or income portfolio.
Bank of America (BAC) 2026 stock outlook: net interest income sensitivity to rate cuts, CCAR capital return capacity, consumer credit quality signals, commercial real estate exposure, and whether BAC fits in a dividend-focused portfolio or 401(k) allocation.
Doosan Enerbility (034020) 2026 outlook for US investors: the small modular reactor (SMR) supply chain opportunity, Korean gas turbine export potential, nuclear renaissance policy tailwinds, and how to access this Korean energy equipment company from US markets.
Celltrion (068270) 2026 outlook for US investors: ZYMFENTRA subcutaneous infliximab US market penetration, PBM formulary dynamics, pipeline beyond the first wave, and how to access this Korean biosimilar leader through OTC markets or ETFs.
LG Chem (051910) after spinning off LG Energy Solution: how US investors can access the parent company, whether the NAC discount closes, petrochemical cycle bottom prospects, and the advanced materials segment's role as a structural growth driver in 2026.
Can Samsung Electronics (005930) reclaim its semiconductor throne in 2026? This analysis covers HBM3E/HBM4 competition with SK Hynix, foundry GAA yield recovery, DRAM/NAND price cycle positioning, and how US investors can access Samsung exposure through OTC ADRs or ETFs.
Full Group 1 May 2026 pay dates (5/7, 5/14, 5/21, 5/28), all 25 Thursday-pay tickers, settlement mechanics, 1099-DIV ROC basis tracking, and Memorial Day impact.
All 30 Group 2 tickers, confirmed May 2026 Friday pay dates (5/8, 5/15, 5/22, 5/29), settlement mechanics, MARO/TSLY/NVDY clarifications, and IRS 1099-DIV tax context.
YieldMax Group 3 Target 25™ May 2026 pay dates (5/6, 5/13, 5/20, 5/27), MSST/NVIT/TEST deep dive, Memorial Day impact on May 25 declaration, and how Target 25™ differs from Maximized.
Since Oct 2025, every YieldMax ETF pays weekly. CONY & MSTY land Thursdays; TSLY & NVDY land Fridays. Full group map, May schedule, and US tax (1099-DIV + ROC) breakdown.
Marvell Technology (MRVL) 2026 analysis: custom ASIC wins with AWS Trainium and Google Axion, optical DSP market share, data center PAM4 switching, automotive Ethernet via Brightlane, and Inphi acquisition synergy status for US investors.
Cloudflare (NET) 2026 analysis: Workers AI inference pricing strategy, Zero Trust competition vs Zscaler and PANW, R2 storage egress-free pricing war with AWS, enterprise pool of funds model, and Matthew Prince's GPU capex approach for US investors.
CrowdStrike (CRWD) 2026 analysis: residual reputational damage from the July 2024 global outage, Falcon Flex bundling mechanics, Charlotte AI attach rate, Preempt-based identity module cross-sell, and module count per customer trajectory for US investors.
Shopify (SHOP) 2026 outlook examining Audiences data monetization, AI suite attach rates, GMV share competition with Amazon aggregators, lessons from the Deliverr divestiture, Shopify Markets international expansion, and the AWS infrastructure migration timeline.
Palo Alto Networks (PANW) 2026 analysis: platformization strategy results, Prisma SASE vs Zscaler, Cortex XSIAM SOC automation, billings recognition accounting, and Nikesh Arora's execution record for US investors.
Airbnb (ABNB) 2026 analysis covering NYC Local Law 18 impact, Barcelona short-term rental ban, host supply saturation dynamics, VRBO and Booking.com competitive pressure, Icon Experiences relaunch, and a practical guide for US investors.
Uber (UBER) 2026 outlook examining the Waymo partnership dynamic, Uber One subscription LTV, Freight margin drag, AB5 gig worker legal overhang in California, and the high-margin advertising business scaling quietly inside the platform.
Walt Disney (DIS) 2026 analysis: Disney+/Hulu/ESPN streaming path to margin, parks pricing elasticity, Marvel and Star Wars franchise fatigue, Bob Iger succession timeline, and ESPN DTC launch. Practical guide for US retail investors.
Snowflake (SNOW) 2026 analysis covering consumption model mechanics, cRPO trajectory, Cortex AI monetization, Databricks Iceberg pressure, and what Sridhar Ramaswamy's roadmap means for investors.
Home Depot (HD) 2026 deep-dive: Pro vs DIY revenue mix shift, SRS Distribution acquisition thesis, housing turnover correlation, aging housing stock structural tailwind, and lumber and weather sensitivity. Analysis for US retail investors.
Adobe (ADBE) 2026 outlook examining Firefly AI monetization progress, post-Figma strategy, Creative Cloud pricing power against Canva competition, EU regulatory risks, and what US investors should do with the stock.
Costco (COST) 2026 analysis: membership renewal rate moat, executive fee pricing power, special dividend cadence history, Kirkland Signature private-label margin, and e-commerce gap versus Amazon. Practical guide for US retail investors.
Qualcomm (QCOM) 2026 outlook covering Apple modem insourcing risk, Snapdragon automotive design-win backlog, Arm royalty dispute, Nuvia PC chip progress, and a practical guide for US investors.
Eli Lilly (LLY) 2026 analysis covering the GLP-1 franchise (Zepbound/Mounjaro), manufacturing capacity bottleneck, compounded semaglutide litigation, and what donanemab and orforglipron mean for the next growth chapter.
Walmart (WMT) 2026 deep-dive covering Walmart+ subscription growth, Walmart Connect advertising, automation capex, grocery market share versus Kroger and Costco, and tariff exposure — practical analysis for US retail investors.
Mastercard (MA) 2026 analysis for US investors examining emerging market growth advantage over Visa, open banking positioning, Mastercard Move remittance infrastructure, and cybersecurity services as a recurring revenue engine.
Should you buy an annuity or max your 401(k) first? We run the bracket-by-bracket breakeven math so you can see exactly when an annuity starts to win — and when it doesn't.
Gold broke $3,000 per ounce in 2026. Here's an honest analysis of where prices are headed, whether gold belongs in your portfolio, and the smartest ways to invest.
Whether you want full early retirement or a strategic career break, this guide breaks down FIRE strategies and micro-retirement planning with honest, current numbers.
A practical breakdown of high-yield savings accounts, CDs, and money market accounts in 2026. Which one earns more, which one is more flexible, and how to use all three together.
A plain-English breakdown of capital gains tax on stock investments in 2026. Short-term vs long-term rates, how to calculate your liability, and legal strategies to reduce your tax bill.
UnitedHealth Group (UNH) 2026 analysis covering Optum Rx PBM regulation risk, Medicare Advantage reimbursement cuts, Change Healthcare cyberattack fallout, DOJ antitrust shadow, and MLR sensitivity for US retail investors.
Visa (V) 2026 analysis for US investors covering cross-border volume recovery, network pricing power, CBDC and stablecoin long-tail risk, Visa Direct B2B expansion, and the DOJ merchant antitrust overhang.
JPMorgan Chase (JPM) 2026 analysis for US investors covering net interest income sensitivity to the Fed path, investment banking fee recovery, CCAR stress test buffer, Jamie Dimon succession, and credit loss provisioning trends.
Berkshire Hathaway (BRK.B) 2026 analysis covering Greg Abel succession, insurance float mechanics, BNSF railroad moat, Apple concentration, and the $300B cash deployment question for US investors.
AGNC's 7–10x leverage amplifies MBS losses into book value erosion. See how duration gap, rate hikes, and ordinary-income taxation compound the risk for US investors.
AMDY's higher AMD-driven premiums come with steeper NAV drift. Compare AMDY vs AMZY on option premium decay, NAV erosion rate, and monthly distribution stability.
Coca-Cola doesn't own most of its factories — its asset-light franchise model is exactly why KO can sustain 60+ years of dividend raises. Here's how the economics work in 2026.
Analysis of DGRO (iShares Core Dividend Growth ETF): holdings, methodology, yield vs SCHD, tech exposure, and tax placement for US income investors.
Set up DRIP at Schwab, Fidelity, or Vanguard. Covers fractional reinvestment, tax implications, and a 30-year simulation showing the power of compounding.
GOOY and FBY are YieldMax ETFs on Alphabet and Meta options. Covers distribution mechanics, AI effects on premiums, NAV drift, and account strategies.
Side-by-side comparison of JEPI and JEPQ — JPMorgan's covered call ETFs. Covers yield, holdings, tax treatment, and drawdown risk for income investors.
JNJ has raised its dividend for 60+ years. Covers post-Kenvue spinoff, talc litigation, patent cliff, and whether JNJ belongs in a dividend portfolio.
KODEX 고배당 and Korean high-dividend ETFs for global investors — holdings, currency and withholding risks, and how to access Korean dividends via EWY.
Korean banks offer Asia's highest dividend yields. Covers KB Financial's ADR vs KRX access, withholding tax, the Value-Up program, and US peer comparison.
MAIN is a top-rated BDC with monthly and special dividends since 2007. Covers its managed structure, NAV track record, credit risk, and tax treatment.
MSTY pays high monthly distributions via MSTR covered calls. Covers Bitcoin volatility, NAV drift, US tax treatment, and how to size it in a portfolio.
NOBL tracks S&P 500 Dividend Aristocrats with 25+ year raise streaks. Covers holdings, yield, SCHD comparison, and best use cases for income investors.
Realty Income (O) has paid monthly dividends for 30+ years. Covers its net lease model, AFFO payout ratio, rate sensitivity, and IRA placement.
Samsung preferred (005935) trades at a 25% discount to common. Covers access from abroad, dividend yield premium, KRX hours, and withholding tax.
Deep dive into SCHD — Schwab's top dividend growth ETF. Covers holdings, yield, expense ratio, IRA placement, and how it stacks up against VYM and JEPI.
Where to hold REITs, BDCs, and dividend stocks across Roth IRA, Traditional IRA, and taxable accounts to cut tax drag. Includes a placement matrix.
TSLY pays monthly income via Tesla covered calls. Covers distribution mechanics, NAV drift risk, and US tax treatment for income investors in 2026.
Compare Vanguard's VYM and Schwab's SCHD on yield, dividend growth, holdings, and tax efficiency to decide which ETF fits your income strategy in 2026.
CONY and NFLY pay weekly distributions instead of monthly. Covers payout mechanics, income drivers, NAV drift, and cash-flow calendar planning.
AAPL's real yield isn't 0.5% — buybacks have retired a third of the float. See how Apple's 2026 capital return strategy stacks up for long-term US investors.
Advanced Micro Devices (AMD) 2026 outlook with key metrics, bull vs bear cases, and practical guidance for US retail investors.
AWS re-accelerated past 19% growth, but Kuiper and AI chip capex are eating into AMZN's free cash flow. Here's what the margin math actually looks like in 2026.
ARM Holdings 2026 outlook with key metrics, v9 royalty ramp, data center CPU share, and Softbank overhang explained for everyday US retail investors.
ASML 2026 outlook with key metrics, High-NA EUV ramp, China export-control impact, and services revenue stability for US retail investors.
Broadcom designs Google's TPU and Meta's MTIA — but how big is that custom silicon revenue slice really? We break down AVGO's AI chip share and dividend case for 2026.
Coinbase 2026 outlook: spot BTC/ETH ETF custody fees, USDC interest share, US perpetual futures launch, and what US retail investors should watch.
Salesforce's Agentforce charges ~$2 per conversation — but does that pricing model actually move the needle toward $1B ARR? We break down the math for US investors in 2026.
Alphabet (GOOGL) 2026 outlook with key metrics, bull and bear cases, and a US investor playbook for search, Gemini, YouTube, and antitrust risk.
Intel 2026 outlook: 18A process ramp, foundry pivot, CHIPS Act funding, dividend cut aftermath, and what US investors should know.
Meta Platforms (META) 2026 outlook with key metrics, bull vs bear cases, and what US retail investors should actually do about it.
Microsoft (MSFT) 2026 outlook with key metrics, bull and bear cases, and a practical playbook for US investors weighing Azure, Copilot and OpenAI exposure.
Micron Technology 2026 outlook with key metrics, HBM3E/HBM4 ramp, DRAM cycle debate, and CHIPS Act funding, for US retail investors.
Netflix 2026 outlook covering the ad tier ramp, live sports strategy, free cash flow inflection, and what US retail investors should watch each quarter.
Nvidia (NVDA) 2026 outlook with key metrics, bull vs bear scenarios, and a practical playbook for US retail investors using brokerages like Schwab or Fidelity.
Oracle 2026 outlook: the OCI hyperscaler push, the massive RPO backlog, Cerner health IT, debt load, and what US investors should watch.
Palantir 2026 outlook: AIP commercial ramp, US government contracts, the 120x multiple debate, and what US retail investors should watch.
Super Micro Computer 2026 outlook: Blackwell liquid-cooled racks, margin pressure vs Dell and HPE, accounting aftermath, and what US investors should watch.
Tesla (TSLA) 2026 outlook: bull vs bear scenarios and a practical playbook for US investors weighing robotaxi and Optimus optionality. Specific valuation figures omitted due to TSLA volatility — check Yahoo Finance or TradingView for current metrics.
Taiwan Semiconductor (TSM) 2026 outlook with key metrics, bull vs bear cases, and a practical guide for US retail investors on ADRs, taxes, and sizing.
After the AI hype cycle, NVDA, AMD, and MSFT trade at stretched multiples. A practical price-to-AI-revenue framework to decide what's still worth buying in 2026.
ETFs vs individual stocks: compare the pros, cons, risks, and time commitment. Includes a practical hybrid strategy that works for most investors in 2026.
10 dividend stocks from the US, Europe, and Asia for reliable passive income. Covers yield, payout growth, DRIP strategy, and international tax considerations.
VOO vs SPY vs IVV side by side: expense ratios, liquidity, dividend yields, and long-term performance. A beginner's guide to S&P 500 index investing.
Learn how to place monthly dividend ETFs across Roth IRA, 401k, and taxable accounts to minimize taxes and maximize returns.
April 2026 YieldMax Group A dividend schedule and per-ETF payout breakdown. Get the latest on TSLY, CONY, APLY, and all 12 Group A tickers.
April 2026 YieldMax Group B dividend schedule and per-ETF payout details. Get the latest on NVDY, AMZY, GOOGY, MSTY, and all Group B tickers.
April 2026 YieldMax Group D dividend schedule and estimated payouts. Get the details on MSFO, DISO, JPMO, PLTY, and all Group D tickers.
April 2026 YieldMax weekly dividend ETF payout schedule for YMAX, YMAG, and ULTY. Week-by-week dividend amounts, investment simulations, and NAV analysis.
18 months of real NVDY ETF investing: dividend history, NAV decay tracking, total return calculations, and honest lessons from holding through volatility.
After October 2025, both CONY and NVDY are weekly payers — CONY in Weekly Group 1 (Thursday pay) and NVDY in Weekly Group 2 (Friday pay). This structural analysis covers underlying volatility, covered-call mechanics, NAV erosion via Return of Capital, and how to read headline yield numbers honestly.
Week 4 (March 23-27) 2026 dividend recap for YieldMax weekly payers YMAX, YMAG, and ULTY. Ex-dates, pay dates, per-share amounts, and 4-week trends.
March Week 3 (3/16-3/20) dividend recap for YMAX, YMAG, and ULTY. Per-share payout data, NAV trends, FOMC impact, and tips for weekly dividend investors.
2026 monthly dividend calendar for YieldMax Group A ETFs — TSLY, CONY, APLY, and more. Ex-dividend, record, and payment dates in one quick-reference table.
2026 dividend calendar for YieldMax Group B ETFs — NVDY, AMZY, GOOGY, and more. Ex-dividend, record, and pay dates in one quick-reference table.
2026 dividend calendar for YieldMax Group D ETFs — MSFO, PLTY, CSPY, and more. Ex-dividend, record, and pay dates in one quick-reference table.